New Key Statistics Module, Z-Score and F-Score
OTCPK:MEDXF Key Ratios
| Market Cap $ M | 29.03 |
| Enterprise Value $ M | 73.10 |
| P/E(ttm) | 3.98 |
| PE Ratio without NRI | 4.44 |
| Forward PE Ratio | 6.62 |
| Price/Book | 1.00 |
| Price/Sales | 0.22 |
| Price/Free Cash Flow | 1.26 |
| Price/Owner Earnings | 5.36 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 115.00 |
| EPS (TTM) $ | 0.30 |
| Beneish M-Score | -2.82 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 78.50 |
| EV-to-EBIT | 5.37 |
| EV-to-EBITDA | 3.78 |
| PEG | -- |
| Shares Outstanding M | 24.46 |
| Net Margin (%) | 5.16 |
| Operating Margin % | 11.04 |
| Pre-tax Margin (%) | -0.77 |
| Quick Ratio | 0.70 |
| Current Ratio | 1.11 |
| ROA % (ttm) | 3.72 |
| ROE % (ttm) | 26.67 |
| ROIC % (ttm) | -64.28 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.64 |
MEDXF Number of Guru Trades
MEDXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MEDXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MEDXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Medexus Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:MEDXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers